98%
921
2 minutes
20
Natural cell-inspired nanoparticles (NCINPs) represent a transformative innovation in nanomedicine, featuring a core-shell structure coated with isolated natural cell membranes (NCMs) that effectively mimic the functions of native cells. The development of NCINPs achieves molecular-level emulation of native cells by precisely reconstructing the hierarchical architecture of the bio-interface, including the structure of the phospholipid bilayer, lipid rafts, protein matrix, and polysaccharide interactions. This advanced biomimetic strategy not only retains the inherent biocompatibility and targeting precision of natural cells but also enables programmable functionalities that surpass those of natural systems, offering enhanced therapeutic potential. In this review, an in-depth introduction to the background of natural cell-inspired research is provided, the current prevalent synthesis methods of NCINPs is delineated, and the application mechanisms based on various types of NCMs, as well as their applications in both benign and malignant diseases are elucidated. However, clinical translation faces significant challenges: complex synthesis, compromised membrane functionality, and unpredictable in vivo behavior. The work comprehensively synthesizes the progress, limitations, and challenges encountered throughout the development of NCINPs, while delineating future prospects. Bridging the translational gap from bench to bedside accelerates the clinical translation of NCINPs and fully realizes their therapeutic potential across diverse medical applications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adma.202505187 | DOI Listing |
Adv Mater
August 2025
Engineering Research Center of Nano-Geomaterials of Ministry of Education, Faculty of Materials Science and Chemistry, China University of Geosciences, Wuhan, 430074, China.
Natural cell-inspired nanoparticles (NCINPs) represent a transformative innovation in nanomedicine, featuring a core-shell structure coated with isolated natural cell membranes (NCMs) that effectively mimic the functions of native cells. The development of NCINPs achieves molecular-level emulation of native cells by precisely reconstructing the hierarchical architecture of the bio-interface, including the structure of the phospholipid bilayer, lipid rafts, protein matrix, and polysaccharide interactions. This advanced biomimetic strategy not only retains the inherent biocompatibility and targeting precision of natural cells but also enables programmable functionalities that surpass those of natural systems, offering enhanced therapeutic potential.
View Article and Find Full Text PDFJ Am Chem Soc
July 2025
State Key Laboratory for Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.
Developing highly efficient and durable membrane electrode assemblies (MEAs) is imperative for the widespread implementation of proton exchange membrane fuel cells (PEMFCs). However, the poor mass transfer efficiency and sluggish oxygen reduction reaction (ORR) kinetics have significantly suppressed the power density and longevity of platinum (Pt)-based MEA in PEMFCs, particularly when using an ultralow Pt loading. Inspired by the functional principles of hemoglobin in red blood cells, we present a Heme-cofactor strategy to create a "respiratory proton-transfer chain" for PEMFCs.
View Article and Find Full Text PDFMater Today Bio
February 2025
Department of Stomatology, China-Japan Union Hospital, Jilin University, 126#Xiantai Street, Jingkai District, Changchun, 130031, PR China.
J Control Release
January 2025
School of Pharmacy, Jiangsu Provincial TCM Engineering Technology Research Center of High Efficient Drug Delivery System, Nanjing University of Chinese Medicine, Nanjing 210023, China; State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufactur
Ischemic stroke (IS), accounting for 87 % of stroke incidences, constitutes a paramount health challenge owing to neurological impairments and irreversible tissue damage arising from cerebral ischemia. Chief among therapeutic obstacles are the restrictive penetration of the blood-brain barrier (BBB) and insufficient targeting precision, hindering the accumulation of drugs in ischemic brain areas. Motivated by the remarkable capabilities of natural membrane-based delivery vehicles in achieving targeted delivery and traversing the BBB, thanks to their biocompatible architecture and bioactive components, numerous membrane-engineered systems such as cells, cell membranes and extracellular vesicles have emerged as promising platforms to augment IS treatment efficacy with the help of nanotechnology.
View Article and Find Full Text PDFAdv Mater
June 2024
Department of Radiation and Medical Oncology, Wenzhou Key Laboratory of Basic Science and Translational Research of Radiation Oncology, Zhejiang Engineering Research Center for Innovation and Application of Intelligent Radiotherapy Technology, The Second Affiliated Hospital and Yuying Children's Hos
Genome editing has the potential to improve the unsatisfactory therapeutic effect of antitumor immunotherapy. However, the cell plasma membrane prevents the entry of almost all free genome-manipulation agents. Therefore, a system can be spatiotemporally controlled and can instantly open the cellular membrane to allow the entry of genome-editing agents into target cells is needed.
View Article and Find Full Text PDF